Stocks Comparison
biote vs Niagen Bioscience: revenue, profit, margins and growth compared
biote brought in $192.2M of revenue in fiscal 2025, Niagen Bioscience $129.4M in fiscal 2025. Revenue changed by -2.5% at biote and +29.9% at Niagen Bioscience on the year before, so Niagen Bioscience grew faster. biote kept 14.1% of its revenue as net profit, Niagen Bioscience 13.4%.
Side by side, latest fiscal year
| BTMD | NAGE | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $192.2M | $129.4M |
| Revenue growth | -2.5% | +29.9% |
| Net income | $27M | $17.4M |
| Net margin | 14.1% | 13.4% |
| Free cash flow | $30.2M | n/a |
| Free cash flow margin | 15.7% | n/a |
| Earnings per share (diluted) | $0.74 | $0.20 |
| Cash | $24.1M | $64.8M |
| Debt | $103.1M | n/a |
| Price to earnings | 1.6 | 15.3 |
| Market value | $43.8M | $241.3M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #256 of 523 · Health care | #282 of 523 · Health care |
Over the years
Questions about biote and Niagen Bioscience
Which is bigger by revenue, biote or Niagen Bioscience?
biote is bigger by revenue: $192.2M in fiscal 2025, against $129.4M for Niagen Bioscience in fiscal 2025.
Which keeps more of its revenue as profit, biote or Niagen Bioscience?
biote had a net margin of 14.1% in fiscal 2025; Niagen Bioscience had 13.4% in fiscal 2025.
Which grew revenue faster, biote or Niagen Bioscience?
In their latest fiscal years revenue changed by -2.5% at biote and +29.9% at Niagen Bioscience.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.